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Exercise and Hormones
increase in RBF and may be an important regulatory mechanism of renal
circulation in pts with CHF.
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Human skeletal alpha actin expression was present in all samples.
Conclusions: The frequency of iNOS expression was increased (p < 0.02)
in right ventricular tissue from patients with head failure irrespective of etiol-
ogy. Although this phenomenon might result from the effects of drug therapy
andlor cardiac surgical procedures, it may be that expression of iNOS, like
AN P, is part of the molecular phenotype of the failing heart Local generation
of increased levels of nitric oxide may contribute to contractile impairment in
patients with valvular and ischemic head disease as well as in patients with
dilated cardiomyopathy.
Nitric oxide is known to exert negative inotropic effects on myocytes. Ini-
tial reports using activity assays have suggested increased generation of
nitric oxide in myocardium from patients with dilated cardiomyopathy and
acute myocarditis. However, myocardial detection of mRNA encoding the
cytokine-inducible form of nitric oxide synthase(iNOS) has not been reported
in patients with heart failure. We extracted total RNA from right ventricular
myocardium obtained from 40 human hearts; explanted hearts -dilated car-
diomyopathy (n ~ 10), ischemic head disease (n ~ 10); intra-operative biop-
sies in patients with compensated heart failure - valvular heart disease (n =
9) ischemic heart disease (n ~ 1); and necropsy specimens (within 6 hours
of death) from subjects who had suffered sudden death from a non-cardiac
cause (n ~ 10). Samples were analyzed using reverse transcription - poly-
merase chain reaction (RT-PCR). Three pairs of oligonucleotide primers were
used that were specific for iNOS, atrial natriuretic peptide (ANP) and human
skeletal alpha actin. Expression of ANP in human ventricular myocardium
has been shown to be a marker of changes in gene expression associated
with heart failure and ventricular remodeling, and human skeletal alpha actin
was used as an internal standard to indicate the presence of non-degraded
mRNA.
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1780-1 I Exercise-induced ST Segment Depression is
Associated with Increases in Endothelin-1
Wendy S. Shear, Cheryl L. lacarella, Rosemary V. Manion, Betsy V. Christensen,
Dianne L. Judd, Robert F. Wilson University of Minnesota, Minneapolis, Minnesota
We have shown previously that plasma [N021(a metabolite of nitric oxide)
rises sharply during exercise in normal subjects, but does not increase sig-
nificantly in patients with exercise-induced ST depression and angiograph-
ically normal coronary arteries. To determine if venous plasma endothelin-
1, a potent endothelial-dependent vasoconstrictor, changes with exercise,
we studied 17 subjects (7 with normal exercise ECGs and 10 with exercise-
induced ST depression ~0.1 mV after the J point) using symptom-limited
exercise treadmill tests. Plasma endothelin-l levels were measured using a
radioimmunoassay at baseline (Basal). peak exercise (Peak). and 5 minutes
post-exercise (post).
Results:
Plasma Endothelin-l (pg/ml)
Pre-CHF Day 10-CHF Day 2!>-CHF Day 30-CHF
EF 53 ± 2 30 ± 4* 24 ± 2*t 21 ± l*t
MAP 106± 2 110 ± 5 101 ± 4 94 ± 6*t
NO 6.8 ± 0.04 96 ± 1.1 10.6± lA* 6.2 ± 0.2"
ANP 37 ± 5 257 ± 85* 574 ± 35*t 572 ± 83*t
cGMP 4.1 ± 0.3 12.5±09* 20.1 ± 2.5*t 193 ± 2.4*t
PRA 0.98 ± OA 1.7 ± 0.7 1.7 ± 08 7.2 ± 2.2*t"
UNaV 44 ± 4 42 ± 2 24 ± 6 16 ± 9*t
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Tracy L. Stevens, Daniel D. Borgeson, Lawrence L. Aahrus, Margaret M. Redfield,
Debra A. Lewis, Paul W. Wennberg, John C. Burnett, Jr. Mayo Clinic and Foundation,
Rochester. MN
Congestive heart failure (CHF), a syndrome which progresses from a com-
pensated to a decompensated state, is characterized by maintenance of
sodium excretion without activation of the renin-angiotensin system (RAS)
to a state of sodium retention with an activated RAS. While a role for atrial
natriuretic peptide (ANP) in maintaining this initial state of compensation
has been advanced, controversy persists with regard to the activity of the
endogenous nitric oxide (NO) system in CHF. Such controversy may reflect
temporal changes in the endogenous NO system not previously observed.
Like ANp, NO also possesses important vasodilatory, natriuretic and renin-
inhibiting actions via activation of cGMP. The objective of the current study
was to determine the temporal changes in plasma nitric oxide as deter-
mined by chemiluminescence and associated changes in plasma ANp, cGMP,
plasma renin activity and sodium excretion. We defined these parameters in
a unique canine model of progressive CHF produced by incremental rapid
ventricular pacing (180 bpm to 240 bpm, n ~ 51 over a 30 day period.
*p < 0.05 Vs Pre-CHF; t p < 0.05 vs Day 1O-CHF; "p < 0.05 vs Day 25-CHF
EF, ejection fraction (%); MAP, mean arterial pressure (mmHg); NO, nitrate
InmollmL); ANp, (pg/mL); cGMP, plasma cGMP(pmollmL); PRA, plasma renin
activity (ng/mL/hrl: UNaV, urinary sodium excretion (mEql24 hr).
These studies demonstrate a unique biphasic response in plasma NO as
characterized by an increase in NO during the initial compensated phase of
CHF, followed by a decrease with the onset of avid sodium retention and
activation of the RAS. These studies provide evidence for NO as a partici-
pant in the adaptive changes in the cardiorenal and humoral systems with
progressive heart failure.
1779-41 Biphasic Alterations in Plasma Nitric Oxide in
Experimental Progressive Heart Failure
RAP RVP CSA RBF RVR
mmH9 mmHg mm 2 ml/min dynes.cm-5
BLl 91 ±4 10 ± 1.0 3.7 ± 03 610 ± 46 11171 ± 1295
ACh 10-8M 88 ± 4 10 ± Og 3.8 ± OA' 1015 ± 118' 6685 ± 723'
1O-7M 87 ± 4 10 ± 0.8 3.9 ± 03' l360± 154' 5188 ± 805'
1O-6M 90 ± 4 11 ± 0.9 4.0 ± 0.3' 1499 ± 181' 4868 ± 660'
BL2 91 ± 3 10 ± 1.0 3.5 ± 0.3 635 ± 30 10275 ± 931
NTG 1O-7M 91 ± 4 10 ± 10 37 ± O.3t 782 ± 80 8842 ± 1060
10-6M 95 ± 4 10 ± 1.0 39 ± 0.3t 753 ± 78 9972 ± 1415
1O-5M 89 ± 3 10± 11 3.9 ± 03t 755 ± 58 8595 ± 809
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1779-51 The Effect of Endothelial Stimulation on the Renal
Circulation in Patients with Chronic Heart Failure
Gregory Cohen, Harinder Gogia, Anilkumar Mehra, P. Anthony N. Chandraratna,
Janet V. Johnson, Uri Elkayam. USC School ofMedicine, Los Angeles, CA
Impairment of renal blood flow (RBF) is common in pts with chronic heart
failure (CHF) and may lead to renal dysfunction. Although abnormal RBF
may be due to depressed cardiac output, individual correlations are weak
and suggest for local vasoregulatory mechanisms. We assessed the role
of endothelium (END) derived nitric oxide (NO) on the renal circulation in
12 pts with CHF. Acetylcholine (ACh) (END-dependent vasodilator) and nitro-
glycerin (NTG) (END-independent vasodilator) were infused in a randomized,
crossover design into the renal artery (RA). Effects on renal arterial (RAP) and
renal venous IRVP) pressures, RA cross sectional area (CSA), RBF and renal
vascular resistance (RVR) were studied. CSA was measured by intravascular
ultrasound and RA flow velocity by a Doppler flow wire. The results were as
follows;
mean ± SEM, *p < 005 vs Normal
Exercise time and peak HR x SBP were similar between the two
groups (13,7 ± 0.8 vs 13.3 ± 0.5 min and 30.0 ± 2.7 vs 29.9 ± 1.4
'p < 0.05 vs Baseline 1 IBL1); t p < 005 vs Baseline 2 (BL2)
Conclusion: 1) Exogenous NO (NTG) causes a vasodilatory effect on re-
nal conductance but not on resistance vessels; 2) In contrast, stimulation
of endothelium-derived NO results in a significant vasodilation of both con-
ductance and resistance vessels. This effect leads to reduction in RVR and
Normal
ST i
29 ± 0.7
3.9 ± 09
1.6 ± 0.5
7.5± 21*
2.2 ± 0.6
5.2 ± 1A
-14 ± 0.7
+3.6 ± 1.8*
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mmHg·beats/min·l 03, respectively). The normaI subjects were younger than
those with exercise-induced ST depression (37 ± 3 vs 57 ± 3 years, p < 0.01).
Conclusions: Endothelin-l, a potent vasoconstrictor, falls with exercise in
normal subjects, but increases in patients with exercise-induced ST segment
depression. Endothelin-l may be one of the mediators of exercise-induced
coronary insufficiency.
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1780-21 Exercise Increases Systemic Nitric Oxide Production
in Men
Stefanie M. Bode-Boger, Rainer H. Boger, Jurgen C Frolich Institute of Clinical
Pharmacology, Medical School. Hannover; Germany
The effects of submaximal exercise on systemic nitric oxide (NO) formation,
as assessed by measuring the urinary excretion rates of NO; and of cyclic
GMP. were compared in 10 endurance-trained and 6 untrained male subjects.
Urinary excretion rates of NO; (by gas chromatography) and cyclic GMP (by
radioimmunoassay) were assesse before and after a 30 min exercise tes1dlt
60% of each subject's individual maximal work capacity in hourly intervals.
Urinary NO; excretion in untrained and trained subjects was comparable at
rest (104 ± 35 vs. 110 ± 19 /lmol/mmol creatinine, p = n.s.). It more than
doubled during exercise in both groups (to 236 ± 88 /lmol/mmol creatinine in
untrained and to 252 ± 39 /lmol/mmol creatinine in trained subjects, each p
< 0.01) and rapidly decreased to baseline within 2 hours after the test. Rest-
ing urinary cyclic GMP excretion was fourfold higher in the athletes than in
the untrained subjects (21 ± 5 vs. 6 ± 1 nmol/mmol creatinine, p < 0.05).
During exercise it increased about twofold in both groups (to 52 ± 12 and
10 ± 1 nmol/mmol creatinine, respectively, each p < 0.01), and returned to
baseline after its end. There was a correlation between urinary cyclic GMP
and NO- excretion (p < 0.05) in both groups. We conclude that acute sub-
maximaT exercise increases the formation of NO in man, as reflected by the
increased urinary excretion of NO; and cyclic GMP. This may contribute to
the vasodilation during physical exercise, and at least partly explain the ben-
eficial effects of physical training in patients with cardiovascular diseases.
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1780-31 Does Estrogen Reduce the Accuracy of Exercise
Electrocardiography in Women?
Anthony P. Morise, Robert Beto, George A. Diamond. West Virginia University,
Morgantown, WV
It has been suggested that estrogen has a role in the genesis of false posi-
tive exercise electrocardiograms in women. We evaluated 1007 men and 832
women with suspected coronary artery disease concerning the accuracy of
exercise electrocardiography. Women were grouped according to estrogen
status (ES): ES- = postmenopausal and not on estrogen replacement and
ES+ = premenopausal (Premen) or on estrogen replacement. Positive exer-
cise ST criteria were 2:1 mm horizontal/downsloping or 2:1.5 mm upsloping
depression. Resu/ts: Overall accuracy: sensitivity 44% and specificity 87%;
receiver operating characteristic curve (ROC) area 76 ± 3. The following table
compares the accuracy of men and subgroups of women.
Number Sensitivity Specificity ROC Area
Men t007 52 ± 7 91 ± 2 84 ± 3
Women 832 34 ± 7 82 ± 2' 64 ± 6'
ES- 317 35 ± 12 79 ± 5' 61 ± 9'
ES+ 515 15± 11 81 ± 2' 46 ± 15'
Premen 259 72 ± 40 91 ± 5" 90 ± 14'
'p < 0.01 vs Men; "p ~ 0.05 vs ES+ or ES-; 'p < 005 vs Women, ES+, or ES-
The heart rate-pressure products for Men (26,600 ± 600) and Premen
(26,500 ± 500) were the same (p = 0.58).
Conclusion: Concerning exercise electrocardiography, both ES+ and ES-
women have lower accuracy than men. However, Premen women (a sub-
group of ES+) had exercise performance and accuracy similar to men, espe-
cially concerning specificity. These results suggest that not all ES+ women
have the same accuracy and argue against a role for naturally occurring es-
trogen as an etiology for false positive results.
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1780-41 ST Segment Depression Risk, Menopause,
Hysterectomy and Exogenous Estrogen in
Asymptomatic Women
Arlan J. AI-Hani, Alice Furumoto-Dawson Sf James Hospital & Health Centers,
Chicago Heights, IL
In a 1993 follow-up survey, the Women Take Heart Project assessed 1992
menopausal status, including hysterectomy, and validated exogenous estro-
gen use (both estrogen replacement therapy and birth control pills) in 5932
women (W) who were examined and treadmill stress tested during 1992.
5449 W provided complete data for these analyses.
Using logistic regression to estimate the relative likelihood of significant ST
segment depression (1 mm at 80 msec) while taking into account age, body
mass index (kg/m2), cholesterol, resting heart rate, supine systolic blood
pressure (SSP, mmHg). educational attainment and weekly aerobic exercise
frequency as continuous variables, and employment, black race and smok-
ing as categorical factors, the effects of estrogen and menopausal status
(pre-menopausal: Pre, menopausal/post: M, and hysterectomy: Hyst) were
examined. Hyst-W were younger than M-W at examination (mean age 56.4
vs. 59.3). and their mean age at hysterectomy was younger than either the
mean age of menopause onset or completion that M-W reported (41 vs. 47
and 50 years old). The overall fit of the model was highly significant (model
chi-square with 14 df = 211.67, P < 0.0001).
Variable B S.E. df Sig Odds Ratio
Age (each addtl yr) 0.009 00047 1 0.0493 1.01
Estrogen Use 0.372 0.0775 1 0.0000 1.45
Reprod Status Overall 3 0.004B
(Pre-menopause: reference category) 1.00
Menopausal/post 01B7 0.05B2 0.0013 1.21
Late hyst «35 yrs) 0.114 0.0636 00725 1.12
Early hyst -0.254 0.0924 0.0059 0.7B
Conclusions: 1) Post-menopausal status, independent of aging, appears
to increase women's cardiovascular disease risk. 2) Exogenous estrogen ap-
pears to increase women's likelihood of responding to exercise stress testing
with ST segment depression.
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1780-51 Training Level Comparison Study: Effects of Exercise
Training Intensity on Insulin and Glucose Levels in
Coronary Patients with "Clustering" of Risk Factors
Mary Ellen Sweeney, Gerald F. Fletcher, Albert Oberman, Barbara J. Fletcher,
Sandra B. Dunbar, Jeannette Lee, Claire R. Rice Emory University, Atlanta, GA;
University ofAlabama, Birmingham, AL
Hyperinsulinemia has been associated with clustering of hypertension, glu-
cose intolerance, elevated cholesterol and obesity. The effect of exercise
training (Ex Tr) intensity on serum glucose (G) and insulin (I) was studied
in 26 of 200 pts with documented coronary artery disease exhibiting risk
factor clustering. Pts were prospectively randomized to high intensity (85%
V02max) Ex Tr or low intensity (50% V02max) Ex Tr, 60 min., 3 x week.
Groups did not differ by age, weight, elevated cholesterol, hypertension or
glucose intolerance at baseline. G and I levels were analyzed in the fasting
state and 1 hour post glucose load at baseline and after 6 mo. of Ex Tr. Data
were analyzed byWilcoxin signed rank number test and reported as medians
with (ranges). There were no significant base to 6 mo. differences in fasting
G and I levels in either group.
Post glucose load results:
Base -=:6;..:M;..:O:.:.:-::-::-_-:-~_::-:-:::-:---:::
High Ex Tr(N = 14) Low Ex Tr (N = 12) High Ex Tr (N = 11 ) Low Ex Tr IN = B)
I (/lIU/ml) 136 137 66' 100
(9-532) (37-1305) 111-29B) (36-137)
G(mg/dl) 20B 197 17B" lB2
(161-50B) 167-400) 176-532) (137-1305)
'p ~ 0007 (within group), "p ~ 0.002 (within group)
We conclude high intensity Ex Tr appears more effective in altering post-
absorptive I and G levels in coronary pts exhibiting clustering of risk factors.
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Effect of Long Term Prostacyclin (PGI2) on Exercise
in Patients with Primary Pulmonary Hypertension
(PPH) Who Have Deteriorated on Maximal
Conventional Therapy
David F. Wax, Robert Garofano, Welton M. Gersony, Robyn J. Barst. Columbia
University, New York, NY
Continuous IV PGI2 has been shown to improve survival and quality of life in
patients with PPH. We used cycle ergometrywith continuous measurement
of gas exchange to evaluate 15 pts (6-57 yrs) with PPH who were treated
with PGI2 after having deteriorated on maximal conventional therapy (CT:
oral vasodilators, cardiac glycosides, diuretics, oxygen and anticoagulation).
Column I shows the performance while on maximal CT 2 to 13 mos before
starting PG12. Column 2 is the baseline performance immediately prior to
starting PGI2. Data are presented as mean ± SO.
